Mizuho Securities Remains Sidelined Following Endo Int'l's (ENDP) Mixed 4Q Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/27/2026
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Oil settles up 2% after Trump rejects return to Iran ceasefire deal terms
- Could SpaceX's orbital compute avoid the political headwinds facing data centers?
- Could Meta's teen settlement be less painful than feared? Citi weighs in
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- First Financial to acquire Hickory Point Bank in $111.3M deal
- Boston Scientific discloses cybersecurity incident causing global disruption
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- Revolution Medicines prices RASONQUE at $39,800 per month
Endo Reports Fourth Quarter And Full Year 2015 Financial Results
February 29, 2016 6:30 AM ESTDUBLIN, Feb. 29, 2016 /PRNewswire/ --
Full year 2015 adjusted diluted EPS of $4.66 exceeds top end of guidance Fourth quarter revenues of $1,074 million brings full year revenues to top end of guidance Fourth quarter reported $1.97 diluted (GAAP) EPS from continuing operations and $1.36 adjusted diluted EPS from continuing operations Company expects 2016 revenues to range from $4.32 billion to $4.52 billion Company expects 2016 reported diluted GAAP earnings per share to range from $2.25 to $2.60 Company updates 2016 adjusted diluted earnings per share to range from $5.85 to... More